TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TXMD TherapeuticsMD

Market Closed 06-12 16:00:00 EDT

2.20

+0.38

+20.88%

盘后2.16

-0.04-1.80%

19:54 EDT

High2.20	Low1.85	Vol259.97K
Open1.85	D1 Closing1.82	Amplitude19.23%
Mkt Cap25.46M	Tradable Cap21.03M	Total Shares11.57M
T/O537.01K	T/O Rate2.72%	Tradable Shares9.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TXMD","market":"US","secType":"STK","nameCN":"TherapeuticsMD","latestPrice":2.2,"timestamp":1781294400000,"preClose":1.82,"halted":0,"volume":259970,"hourTrading":{"tag":"盘后","latestPrice":2.1603,"preClose":2.2,"latestTime":"19:54 EDT","volume":11781,"amount":25816.9993,"timestamp":1781308494160,"change":-0.0397,"changeRate":-0.018045,"amplitude":0.018182},"delay":0,"changeRate":0.20879120879120885,"floatShares":9560749,"shares":11574362,"eps":0.015465,"marketStatus":"Market Closed","change":0.38,"latestTime":"06-12 16:00:00 EDT","open":1.85,"high":2.2,"low":1.85,"amount":537008.2003649999,"amplitude":0.192308,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.015465,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1366689600000,"exchange":"NASDAQ","adjPreClose":1.82,"preHourTrading":{"tag":"盘前","latestPrice":1.78,"preClose":1.82,"latestTime":"07:21 EDT","volume":12,"amount":21.36,"timestamp":1781263294810,"change":-0.04,"changeRate":-0.021978,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.1603,"preClose":2.2,"latestTime":"19:54 EDT","volume":11781,"amount":25816.9993,"timestamp":1781308494160,"change":-0.0397,"changeRate":-0.018045,"amplitude":0.018182},"volumeRatio":2.6622230237929605,"impliedVol":0.43,"impliedVolPercentile":0.1992},"requestUrl":"/m/hq/s/TXMD/tweets","defaultTab":"tweets","newsList":[{"id":"2642232446","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642232446","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642232446?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:32","pubTimestamp":1781213520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 2.15% to $1.82 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 2.54% to 25,809.66 and the Dow Jones Industrial Average  rising 1.86% to 50,848.75.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 38.31% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  fell 0.08% to $224.77.Trading volume  eclipsed its 50-day average volume of 31,408.Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642479400","title":"TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2642479400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642479400?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:30","pubTimestamp":1781127000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 1.06% to $1.86 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.98% to 25,169.50 and Dow Jones Industrial Average  falling 1.87% to 49,918.78.TherapeuticsMD Inc. closed 36.95% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc.  fell 0.21% to $224.95.Trading volume  eclipsed its 50-day average volume of 31,433.Data source: Dow Jones Market Data, FactSet. Data compiled June 10, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431069","title":"TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431069","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431069?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:34","pubTimestamp":1780950840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of TherapeuticsMD Inc. slid 5.5% to $1.88 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.9% to 25,929.66 and the Dow Jones Industrial Average falling 0.2% to 50,786.01.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 36.3% short of its 52-week high of $2.95, which the company reached on January 27th.The stock underperformed when compared to some of its peers, as AbbVie Inc. fell 1.8% to $223.07.Trading volume totaled 173,719, compared to the 50-day average of 26,718.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641584160","title":"TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2641584160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641584160?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:31","pubTimestamp":1780608660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  advanced 1.52% to $2.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 1.73% to 51,561.93 and the NASDAQ Composite Index  falling 0.09% to 26,830.96.The stock's rise snapped a three-day losing streak.TherapeuticsMD Inc. closed 32.20% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.  rose 3.60% to $224.94.Trading volume  remained 12,551 below its 50-day average volume of 24,320.Data source: Dow Jones Market Data, FactSet. Data compiled June 4, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640260669","title":"TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640260669","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640260669?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:31","pubTimestamp":1780435860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 3.77% to $2.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.03% to 27,093.90 and the Dow Jones Industrial Average  rising 0.45% to 51,307.79.This was the stock's second consecutive day of losses.TherapeuticsMD Inc. closed 30.85% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.  rose 1.16% to $215.40.Trading volume  eclipsed its 50-day average volume of 21,118.Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639706066","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2639706066","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639706066?lang=en_us&edition=fundamental","pubTime":"2026-05-30 05:30","pubTimestamp":1780090200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 1.42% to $2.14 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.20% to 26,972.62 and the Dow Jones Industrial Average  rising 0.72% to 51,032.46.TherapeuticsMD Inc. closed 27.46% below its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Friday, as AbbVie Inc.  fell 0.42% to $217.72.Trading volume  remained 6,875 below its 50-day average volume of 21,446.Data source: Dow Jones Market Data, FactSet. Data compiled May 29, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357252","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357252?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:33","pubTimestamp":1779399180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 1.44% to $2.11 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 0.09% to 26,293.10 and the Dow Jones Industrial Average  rising 0.55% to 50,285.66.This was the stock's fifth consecutive day of gains.TherapeuticsMD Inc. closed 28.47% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Thursday, as AbbVie Inc.  rose 1.04% to $214.50.Trading volume  remained 8,571 below its 50-day average volume of 21,467.Data source: Dow Jones Market Data, FactSet. Data compiled May 21, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637769618","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2637769618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637769618?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:29","pubTimestamp":1779312540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 1.96% to $2.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.54% to 26,270.36 and the Dow Jones Industrial Average  rising 1.31% to 50,009.35.This was the stock's fourth consecutive day of gains.TherapeuticsMD Inc. closed 29.49% short of its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  fell 0.68% to $212.30.Trading volume  remained 11,924 below its 50-day average volume of 21,992.Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636700109","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2636700109","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636700109?lang=en_us&edition=fundamental","pubTime":"2026-05-19 05:30","pubTimestamp":1779139800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  inched 1.00% higher to $2.02 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.32% to 49,686.12 and the NASDAQ Composite Index  falling 0.51% to 26,090.73.This was the stock's second consecutive day of gains.TherapeuticsMD Inc. closed 31.53% short of its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Monday, as AbbVie Inc.  fell 0.47% to $209.41.Trading volume  remained 10,167 below its 50-day average volume of 22,196.Data source: Dow Jones Market Data, FactSet. Data compiled May 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635759140","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2635759140","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635759140?lang=en_us&edition=fundamental","pubTime":"2026-05-14 05:30","pubTimestamp":1778707800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rallied 3.59% to $2.02 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.20% to 26,402.34 and the Dow Jones Industrial Average  falling 0.14% to 49,693.20.The stock's rise snapped a five-day losing streak.TherapeuticsMD Inc. closed 31.53% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock outperformed some of its competitors Wednesday, as AbbVie Inc.  rose 0.31% to $208.50.Trading volume  eclipsed its 50-day average volume of 23,315.Data source: Dow Jones Market Data, FactSet. Data compiled May 13, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223484","title":"TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223484","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223484?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:19","pubTimestamp":1778620777,"startTime":"0","endTime":"0","summary":"TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.01 per share. This is a 116.67 percent increase over losses of $(0.06) per share from the same period last year.  The company reported $724.000 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52509564/therapeuticsmd-q1-eps-0-01-up-from-0-06-yoy-sales-724-000k-up-from-393-000k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TherapeuticsMD Q1 EPS $0.01 Up From $(0.06) YoY, Sales $724.000K Up From $393.000K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722340","title":"TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722340","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722340?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:18","pubTimestamp":1778620735,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $724K vs. $393K y/y. The Company continues to evaluate a variety of strategic alternatives that may include, but are not limited...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/therapeuticsmd-reports-q1-eps-1c-vs-6c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/therapeuticsmd-reports-q1-eps-1c-vs-6c-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635287432","title":"TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2635287432","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635287432?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:47","pubTimestamp":1778618822,"startTime":"0","endTime":"0","summary":"TherapeuticsMD ( ($TXMD) ) has provided an update. TherapeuticsMD, Inc. reported on May 12, 2026, that it generated $103,000 in net income from con...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-quarterly-profit-evaluates-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/therapeuticsmd-reports-quarterly-profit-evaluates-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TXMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247910","title":"TherapeuticsMD swings to FY26 Q1 profit of $103,000; revenue rises 84.2% to $724,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247910","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247910?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:08","pubTimestamp":1778616485,"startTime":"0","endTime":"0","summary":"TherapeuticsMD posted net income from continuing operations of $103,000 for first-quarter 2026, swinging from a loss a year earlier.License revenue rose 84.22% year over year to $724,000, driven primarily by the Mayne License Agreement.Total operating expenses fell 13.6% to $1.45 million, reflecting absence of a 2025 write-off and lower professional fees and share-based compensation.Cash and cash equivalents totaled $8.4 million at March 31, 2026.Company continued evaluating strategic alternatives, including potential acquisition, merger, business combination, or asset sale.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL33PTxg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635622582","title":"TherapeuticsMD Inc - Company Continues to Evaluate Strategic Alternatives Including Acquisition or Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2635622582","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635622582?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXBF313E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TXMD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635524719","title":"Press Release: TherapeuticsMD Announces First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635524719","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635524719?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"TherapeuticsMD, Inc.  , a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended March 31, 2026.--  Net income from continuing operations totaled $103 thousand, compared. to a net loss of $636 thousand for the first quarter of 2025.--  The Company recorded $724 thousand in license revenue, primarily from. the Mayne License Agreement, an increase of $331 thousand, compared to. $393 thousand in license revenue for the first quarter of 2025. The. increase is attributable to changes in sales of licensed products.thousand, or 13.6%, compared to $1,674 thousand for the first quarter of. expense recognized in 2025, as well as lower professional fees and. that may include, but are not limited to, an acquisition, merger, other. business combination, sale of assets, or other strategic transactions. This press release by TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limite","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634531162","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2634531162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634531162?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:30","pubTimestamp":1778535000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slid 1.01% to $1.96 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 0.10% to 26,274.13 and the Dow Jones Industrial Average  rising 0.19% to 49,704.47.This was the stock's fourth consecutive day of losses.TherapeuticsMD Inc. closed 33.56% short of its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 0.61% to $202.78.Trading volume  remained 50 below its 50-day average volume of 23,231.Data source: Dow Jones Market Data, FactSet. Data compiled May 11, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467099","title":"TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467099?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:32","pubTimestamp":1778275920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  slipped 1.49% to $1.98 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 1.71% to 26,247.08 and the Dow Jones Industrial Average  rising 0.02% to 49,609.16.This was the stock's third consecutive day of losses.TherapeuticsMD Inc. closed 32.88% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc.  fell 0.57% to $201.55.Trading volume  eclipsed its 50-day average volume of 22,353.Data source: Dow Jones Market Data, FactSet. Data compiled May 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633927727","title":"TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2633927727","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633927727?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:32","pubTimestamp":1778016720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  rose 2.48% to $2.07 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.03% to 25,326.13 and the Dow Jones Industrial Average  rising 0.73% to 49,298.25.TherapeuticsMD Inc. closed 29.83% below its 52-week high of $2.95, which the company reached on January 27th.The stock outperformed some of its competitors Tuesday, as AbbVie Inc.  fell 0.98% to $206.11.Trading volume  eclipsed its 50-day average volume of 21,630.Data source: Dow Jones Market Data, FactSet. Data compiled May 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633617729","title":"TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2633617729","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633617729?lang=en_us&edition=fundamental","pubTime":"2026-05-05 05:31","pubTimestamp":1777930260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of TherapeuticsMD Inc.  shed 2.42% to $2.02 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.19% to 25,067.80 and Dow Jones Industrial Average  falling 1.13% to 48,941.90.TherapeuticsMD Inc. closed 31.53% below its 52-week high of $2.95, which the company achieved on January 27th.The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc.  rose 0.76% to $208.16.Trading volume  remained 13,056 below its 50-day average volume of 21,811.Data source: Dow Jones Market Data, FactSet. Data compiled May 4, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.therapeuticsmd.com","stockEarnings":[{"period":"1week","weight":0.1055},{"period":"1month","weight":0.0891},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.2571},{"period":"1year","weight":0.8333},{"period":"ytd","weight":0.3497}],"compareEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.12},{"period":"6month","weight":0.088},{"period":"1year","weight":0.2286},{"period":"ytd","weight":0.0877}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.069114},{"month":2,"riseRate":0.461538,"avgChangeRate":-0.035452},{"month":3,"riseRate":0.307692,"avgChangeRate":-0.013291},{"month":4,"riseRate":0.461538,"avgChangeRate":-0.016451},{"month":5,"riseRate":0.571429,"avgChangeRate":0.00831},{"month":6,"riseRate":0.571429,"avgChangeRate":0.003091},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.043284},{"month":8,"riseRate":0.461538,"avgChangeRate":0.045617},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.025286},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.071876},{"month":11,"riseRate":0.615385,"avgChangeRate":0.054051},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.035764}],"exchange":"NASDAQ","name":"TherapeuticsMD","nameEN":"TherapeuticsMD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TherapeuticsMD,TXMD,TherapeuticsMD股票,TherapeuticsMD股票老虎,TherapeuticsMD股票老虎国际,TherapeuticsMD行情,TherapeuticsMD股票行情,TherapeuticsMD股价,TherapeuticsMD股市,TherapeuticsMD股票价格,TherapeuticsMD股票交易,TherapeuticsMD股票购买,TherapeuticsMD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TherapeuticsMD(TXMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TherapeuticsMD(TXMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}